nations, most notably India and China. Importantly,
pharmaceutical and biotechnological companies are increasingly delegating the
responsibility of clinical trials to contract research organisations (CROs).
This visiongain report investigates the global market for such services,
providing forec
ECTED] or call +44(0)2075499946
Please feel free to contact me should you have any questions, or wish to
purchase a copy, I look forward to hearing from you.
Kind Regards,
Justyna Drozdzal
Visiongain - Ltd.
Conference Agenda
Day One - Workshop - 3rd September 2008
anbaxy’s generic Lipitor, in key markets, the legal challenges
surrounding the number one drug have set a new benchmark for pharmaceutical
companies protecting branded products. Industry observers including Visiongain
predicts that Pfizer’s crises are far from over, as the high revenue
streams of
nd China. Importantly,
pharmaceutical and biotechnological companies are increasingly delegating the
responsibility of clinical trials to contract research organisations (CROs).
This visiongain report investigates the global market for such services,
providing forecasts for revenues and exp